Literature DB >> 1835431

Altered calcium handling in left ventricular pressure-overload hypertrophy as detected with aequorin in the isolated, perfused ferret heart.

L A Bentivegna1, L W Ablin, Y Kihara, J P Morgan.   

Abstract

The purpose of this study was to test the hypothesis that systolic and diastolic dysfunction in left ventricular pressure-overload hypertrophy is caused by abnormal intracellular calcium handling. Experiments were performed with intact, buffer-perfused, isovolumic ferret hearts (n = 9 hypertrophied, n = 9 control) that were loaded with the bioluminescent indicator aequorin to monitor changes in cytoplasmic calcium. In each experiment, left ventricular pressure and intracellular calcium transients were simultaneously recorded. Compared with their age-matched controls, significant hypertrophy of the left ventricle developed 4 weeks after postvalvular aortic banding; at the time the animals were killed, the left ventricular weight/body weight ratio was increased in the banded animals (5.3 x 10(-3) versus 3.6 x 10(-3), p less than 0.001). As indicated by the diastolic pressure-volume relation, left ventricular distensibility was significantly diminished in the hypertrophied hearts. In comparison to the controls, the hypertrophied hearts demonstrated a prolonged duration of isovolumic contraction (time to 90% decline from peak: 278 +/- 5.4 versus 247 +/- 10.2 msec, p less than 0.05), but a marked decrease in peak systolic midwall stress (22.4 +/- 5.0 versus 38.6 +/- 5.7 g/cm2, p less than 0.05). The increased duration of isovolumic contraction correlated with a similar prolongation of the calcium transient (time to 90% decline from peak: 245 +/- 19.5 versus 127 +/- 13.2 msec, p less than 0.05), indicating that the rate of sequestration and perhaps release of calcium by the sarcoplasmic reticulum is decreased in hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835431     DOI: 10.1161/01.res.69.6.1538

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 2.  Mitochondria and arrhythmias.

Authors:  Kai-Chien Yang; Marcelo G Bonini; Samuel C Dudley
Journal:  Free Radic Biol Med       Date:  2014-04-05       Impact factor: 7.376

3.  Enhanced NCLX-dependent mitochondrial Ca2+ efflux attenuates pathological remodeling in heart failure.

Authors:  Joanne F Garbincius; Timothy S Luongo; Pooja Jadiya; Alycia N Hildebrand; Devin W Kolmetzky; Adam S Mangold; Rajika Roy; Jessica Ibetti; Mary Nwokedi; Walter J Koch; John W Elrod
Journal:  J Mol Cell Cardiol       Date:  2022-03-28       Impact factor: 5.763

4.  Bioenergetic abnormalities associated with severe left ventricular hypertrophy.

Authors:  J Zhang; H Merkle; K Hendrich; M Garwood; A H From; K Ugurbil; R J Bache
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Hypertrophic gene expression induced by chronic stretch of excised mouse heart muscle.

Authors:  Anna M Raskin; Masahiko Hoshijima; Eric Swanson; Andrew D McCulloch; Jeffrey H Omens
Journal:  Mol Cell Biomech       Date:  2009-09

6.  Mechanical and energetic changes in short-term volume and pressure overload of rabbit heart.

Authors:  H Kiriazis; C L Gibbs; G Kotsanas; I R Young
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

7.  The Dysfunctional Scenario of the Major Components Responsible for Myocardial Calcium Balance in Heart Failure Induced by Aortic Stenosis.

Authors:  Vitor Loureiro da Silva; Sérgio Luiz Borges de Souza; Gustavo Augusto Ferreira Mota; Dijon H S Campos; Alexandre Barroso Melo; Danielle Fernandes Vileigas; Paula Grippa Sant'Ana; Priscila Murucci Coelho; Silméia Garcia Zanati Bazan; André Soares Leopoldo; Antônio Carlos Cicogna
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.